SEC Form 4 · accession 0000899243-15-003612
BG Medicine, Inc. · BGMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Stephen P Hall
Officer — EVP & Chief Financial Officer
Period of report
Aug 15, 2015
Accepted (ET)
Aug 19, 2015 · 8:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001407038
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 15, 2015 | F | 7,505 | $0.83 | D | 39,995 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Relates to shares withheld for payment of tax liability upon vesting of restricted stock units ("RSUs"). The RSUs were granted on October 16, 2014 and vested as to 50% on August 15, 2015, resulting in a net issuance to the holder of 16,245 shares.
- F2Represents 16,245 shares of common stock and 23,750 RSUs.